Spots Global Cancer Trial Database for Reducing Lung Cancer-Related Anxiety (RELAX)

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Reducing Lung Cancer-Related Anxiety (RELAX)

Official Title: Reducing Lung Cancer-Related Anxiety (RELAX)

Study ID: NCT02063828

Conditions

Lung Cancer

Interventions

Group A - Device guided breathing low dose

Group B - Device guided breathing high dose

Group C - Usual Breathing Control Group

Study Description

Brief Summary: The purpose of this research study is to compare the effects of music and different levels of device-guided breathing on anxiety and shortness of breath in lung cancer survivors.

Detailed Description: OBJECTIVES 1. To assess feasibility (accrual, participation, adherence, retention) of a randomized study of device-guided breathing and music in 75 post-treatment lung cancer survivors with significant anxiety. 2. To obtain preliminary data on the variability and efficacy of two doses of a device-guided breathing intervention versus a music control group for reducing anxiety (primary outcome) and for improving self-reported dyspnea and respiratory functioning (secondary outcomes) in post-treatment lung cancer survivors. 3. To select the optimal dose of the device-guided breathing intervention (15 minutes once/day or twice/day) for subsequent randomized study.